Enovis Corp. (ENOV)
22.38
-0.21
(-0.93%)
USD |
NYSE |
Feb 09, 16:00
22.38
0.00 (0.00%)
After-Hours: 20:00
Enovis EPS Diluted (Quarterly) : -9.990 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Repligen Corp. | 0.2638 |
| Twist Bioscience Corp. | -0.4995 |
| Abbott Laboratories | 1.017 |
| Accuray, Inc. | -0.1138 |
| Plus Therapeutics, Inc. | -0.0412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -570.87M |
| Revenue (Quarterly) | 548.91M |
| Total Expenses (Quarterly) | 1.120B |
| Enterprise Value | 2.703B |
| Gross Profit Margin (Quarterly) | 52.24% |
| Profit Margin (Quarterly) | -104.0% |
| Earnings Yield | -108.2% |
| Normalized Earnings Yield | -37.18 |